Middle East Single-use Bioprocessing Market To Reach $2.37 Billion By 2033

Middle East Single-use Bioprocessing Market Growth & Trends

The Middle East single-use bioprocessing market size is projected to reach USD 2.37 billion by 2033, growing at a CAGR of 15.36% during the forecast period, according to a new report by Grand View Research, Inc. The market is expanding steadily, driven by increasing biologics manufacturing, rising investments in biopharmaceutical R&D, and supportive government initiatives. Countries like Saudi Arabia and the UAE are leading adoption, supported by growing clinical research infrastructure and partnerships with global suppliers. Expanding contract manufacturing capabilities and the rising demand for efficient, scalable production systems further accelerate regional market penetration.

Furthermore, biologics manufacturing facilities' rapid expansion is driven by increasing demand for vaccines, monoclonal antibodies, and other advanced therapeutics. Countries such as Saudi Arabia, the UAE, and Qatar invest heavily in state-of-the-art bioprocessing plants to strengthen local production capabilities and reduce reliance on imports. This growth is further supported by government-backed healthcare initiatives, favorable regulatory frameworks, and collaborations with leading global biopharma companies, enabling the adoption of advanced single-use technologies that offer flexibility, scalability, and faster turnaround times in biologics production.

However, a limited-skilled workforce is capable of operating advanced bioprocessing technologies. This shortage slows the adoption of single-use systems, as trained personnel are essential for ensuring efficient, compliant, and high-quality biologics production. Although governments and private institutions are initiating training programs and collaborations with global experts, bridging the talent gap remains a key challenge for scaling bioprocessing operations across the region.

 Request a free sample copy or view report summary: Middle East Single-use Bioprocessing Market Report

Middle East Single-use Bioprocessing Market Report Highlights

• By product, simple & peripheral elements dominated the market in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This dominance is driven by their widespread use in flexible, cost-efficient, and scalable biologics production processes.

• By workflow, upstream dominated the market in 2024 with a market share of 58.20% and is anticipated to grow at the fastest CAGR over the forecast period. This dominance is driven by increasing adoption of single-use systems in cell culture and biologics production. However, fermentation is anticipated to grow significantly over the forecast period.

• By end use, the biopharmaceutical manufacturer segment led the market in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This segment growth is driven by the rising biologics production and growing investments in R&D and contract manufacturing capabilities.

• The key players operating in the market include Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Avantor, Inc., Eppendorf SE, Corning Incorporated, Boehringer Ingelheim International GmbH, Lonza, and Infors AG, among others. 

Middle East Single-use Bioprocessing Market Segmentation

Grand View Research has segmented the Middle East single-use bioprocessing market based on product, workflow, end use, and country:

Middle East Single-use Bioprocessing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Simple & Peripheral Elements

  • Tubing, Filters, Connectors, & Transfer Systems

  • Bags

  • Sampling Systems

  • Probes, Sensors, & Flow Meters

    • pH Sensor

    • Oxygen Sensor

    • Pressure Sensors

    • Temperature Sensors

    • Conductivity Sensors

    • Flow Meters & Sensors

    • Others

  • Others

• Apparatus & Plants

  • Bioreactors

    • Upto 1000L

    • Above 1000L to 2000L

    • Above 2000L

  • Mixing, Storage, & Filling Systems 

  • Filtration System

  • Chromatography Systems

  • Pumps

  • Others

• Work Equipment

  • Cell Culture System

  • Syringes

  • Others

Middle East Single-use Bioprocessing Workflow Outlook (Revenue, USD Million, 2021 - 2033)

• Upstream

• Fermentation

• Downstream

Middle East Single-use Bioprocessing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceutical Manufacturer

  • CMOs & CROs

  • In-house Manufacturer

• Academic & Clinical Research Institutes

Middle East Single-use Bioprocessing Country Outlook (Revenue, USD Million, 2021 - 2033)

• Saudi Arabia

• UAE

• Kuwait

• Qatar

• Oman

List of Key Players in the Middle East Single-use Bioprocessing Market

• Sartorius AG

• Danaher Corporation

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Avantor, Inc.

• Eppendorf SE

• Corning Incorporated

• Boehringer Ingelheim International GmbH

• Lonza

• Infors AG